NASDAQ:GLTO

Galecto News Headlines

$6.28
+0.43 (+7.35 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.91
Now: $6.28▼
$6.54
50-Day Range
$5.85
MA: $8.62▼
$12.40
52-Week Range
$5.77
Now: $6.28▼
$17.99
Volume169,100 shs
Average Volume30,943 shs
Market Capitalization$158.65 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Galecto (NASDAQ GLTO) News Headlines Today

SourceHeadline
-$0.46 EPS Expected for Galecto, Inc. (NASDAQ:GLTO) This Quarter-$0.46 EPS Expected for Galecto, Inc. (NASDAQ:GLTO) This Quarter
americanbankingnews.com - April 2 at 8:10 AM
SVB Leerink Weighs in on Galecto, Inc.s Q1 2021 Earnings (NASDAQ:GLTO)SVB Leerink Weighs in on Galecto, Inc.'s Q1 2021 Earnings (NASDAQ:GLTO)
americanbankingnews.com - April 1 at 7:30 AM
Short Interest in Galecto, Inc. (NASDAQ:GLTO) Rises By 55.5%Short Interest in Galecto, Inc. (NASDAQ:GLTO) Rises By 55.5%
americanbankingnews.com - March 31 at 10:58 AM
Galecto Reports Financial Results for the Year Ended December 31, 2020 and Provides a Corporate UpdateGalecto Reports Financial Results for the Year Ended December 31, 2020 and Provides a Corporate Update
finance.yahoo.com - March 29 at 10:36 AM
Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139
finance.yahoo.com - March 23 at 1:12 PM
UPDATE: Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139UPDATE: Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139
finance.yahoo.com - March 23 at 1:12 PM
Galecto (NASDAQ:GLTO) Price Target Cut to $12.00Galecto (NASDAQ:GLTO) Price Target Cut to $12.00
americanbankingnews.com - March 22 at 9:48 AM
SVB Leerink Cuts Galecto (NASDAQ:GLTO) Price Target to $16.00SVB Leerink Cuts Galecto (NASDAQ:GLTO) Price Target to $16.00
americanbankingnews.com - March 22 at 9:08 AM
Galecto Announces Outcome of Data Safety Monitoring Board Interim Review of Phase 2b GALACTIC-1 Study of GB0139 for Idiopathic Pulmonary Fibrosis: DSMB Recommends Study to Continue with ModificationsGalecto Announces Outcome of Data Safety Monitoring Board Interim Review of Phase 2b GALACTIC-1 Study of GB0139 for Idiopathic Pulmonary Fibrosis: DSMB Recommends Study to Continue with Modifications
finance.yahoo.com - March 15 at 11:42 AM
Galecto to Present at Upcoming Investor ConferencesGalecto to Present at Upcoming Investor Conferences
finance.yahoo.com - February 9 at 8:34 AM
We Think Galecto (NASDAQ:GLTO) Can Afford To Drive Business GrowthWe Think Galecto (NASDAQ:GLTO) Can Afford To Drive Business Growth
finance.yahoo.com - January 29 at 9:28 AM
Galecto Appoints Anne Prener to its Board of DirectorsGalecto Appoints Anne Prener to its Board of Directors
finance.yahoo.com - January 8 at 8:12 AM
Galecto to Take Part in Two Panel Discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access EventGalecto to Take Part in Two Panel Discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
finance.yahoo.com - January 4 at 6:53 PM
Galecto Inc.Galecto Inc.
barrons.com - December 31 at 11:38 PM
Galecto Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate UpdateGalecto Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
finance.yahoo.com - December 11 at 10:14 AM
Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF BiomarkersGalecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers
finance.yahoo.com - November 30 at 8:23 AM
Galecto Appoints Experienced Healthcare Executive Jayson Dallas to Board of DirectorsGalecto Appoints Experienced Healthcare Executive Jayson Dallas to Board of Directors
markets.businessinsider.com - November 23 at 4:37 PM
This page was last updated on 4/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.